News & Articles

Welcome to our News & Article web page. Here you will find The RYR-1 Foundation’s monthly newsletters, news/press releases, and pertinent medical journal articles.

There is growing medical literature on RYR-1-Related Diseases (RYR-1-RD). Please email info@ryr1.org if there are articles that you think would be valuable to post here. The most recent medical journal articles can be found on PubMed below.

PubMed RYR-1-RD Medical Journal Articles

Disease Trajectories of a Large French Cohort of 142 Congenital Myopathy Patients in Adult Age

Disease Trajectories of a Large French Cohort of 142 Congenital Myopathy Patients in Adult Age

Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 Channel

Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 Channel

Obstetric and gynaecological features in females carrying variants in the skeletal muscle ryanodine receptor type 1 (RYR1) gene: a questionnaire study

Obstetric and gynaecological features in females carrying variants in the skeletal muscle ryanodine receptor type 1 (RYR1) gene: a questionnaire study

A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps

A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps

A Clinical Approach to Rhabdomyolysis

A Clinical Approach to Rhabdomyolysis

Oral Dantrolene for Myopathic Symptoms in Malignant Hyperthermia–Susceptible Patients: A 25-Year Retrospective Cohort Study of Adverse Effects and Tolerability

Oral Dantrolene for Myopathic Symptoms in Malignant Hyperthermia–Susceptible Patients: A 25-Year Retrospective Cohort Study of Adverse Effects and Tolerability

SUPPORT US

Donate

The RYR-1 Foundation is a non-profit, 501(c)(3), public charity--your donation is tax-deductible.

FUNDRAISE

Host A Fundraiser

Thank you for your interest in raising funds to support The RYR-1 Foundation. Our success depends on the initiative of supporters like YOU.